Agnieszka Justyna Rybarczyk-Pirek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Agnieszka Justyna Rybarczyk-Pirek has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Marcin Palusiak
Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland
17 shared publications - Kinga Wzgarda-Raj
Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland
14 shared publications - Sławomir Wojtulewski
Department of Structural Chemistry, Faculty of Chemistry, University of Bialystok, Ciołkowskiego 1K, 15-245 Bialystok, Poland
12 shared publications Janusz Zakrzewski
11 shared publications- Magdalena Małecka
Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland
9 shared publications - Bogna Rudolf
University of Lodz, Faculty of Chemistry, Department of Organic Chemistry, Tamka 12, 91-403 Lodz, Poland
7 shared publications
Latest Publications
- 19 August 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 82 (9) , 562-575
Multicomponent crystals of nitroimidazole drugs with trithiocyanuric acid: two competing drug–coformer supramolecular motifs
Cocrystal structures formed by trithiocyanuric acid (TTCA) and selected nitroimidazole derivatives, dimetridazole (DMZ·TTCA, C 5 H 7 N 3 O 2 ·C 3 H 3 N 3 S 3 ), tinidazole (TNZ·TTCA·MeOH, C 8 H 13 N 3 O 4 S·C 3 H 3 N 3 S 3 ·CH 3 OH), ornidazole (ONZ·TTCA·MeOH, C 7 H 10 ClN 3 O 3 ·C 3 H 3 N 3 S 3 ·CH 3 OH, and ONZ·TTCA·H 2 O, C 7 H 10 ClN 3 O 3 ·C 3 H 3 N 3 S 3 ·H 2 O) and ronidazole (RNZ·TTCA and 2RNZ·2TTCA, both C 6 H 8 N 4 O 4 ·C 3 H 3 N 3 S 3 ) were investigated to identify recurring drug–coformer aggregation patterns and factors determining supramolecular architecture. Structural analysis showed that TTCA adopts two principal supramolecular motifs: the hydrogen-bonded R 2 2 (8) dimer and linear chain assemblies. Two dominant drug–coformer binding schemes were identified. The first involves N—H...N hydrogen bonding in the para position relative to the TTCA dimer, leading to four-molecule assemblies, which are accompanied by heteronuclear hydrogen bonding in the ortho position. The second motif is associated with TTCA linear chains, where drug molecules are linked through N—H...N interactions and further stabilized by direct intermolecular or solvent-mediated hydrogen bonding. The polymorphic structure 2RNZ·2TTCA combines both supramolecular strategies within a single-crystal architecture. Hirshfeld surface analysis and intermolecular energy calculations confirmed the importance of hydrogen-bond competition in determining the crystal packing and supramolecular organization in TTCA-based cocrystals.
- 19 August 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 82 (9) , 562-575
Multicomponent crystals of nitroimidazole drugs with trithiocyanuric acid: two competing drug–coformer supramolecular motifs
Cocrystal structures formed by trithiocyanuric acid (TTCA) and selected nitroimidazole derivatives, dimetridazole (DMZ·TTCA, C 5 H 7 N 3 O 2 ·C 3 H 3 N 3 S 3 ), tinidazole (TNZ·TTCA·MeOH, C 8 H 13 N 3 O 4 S·C 3 H 3 N 3 S 3 ·CH 3 OH), ornidazole (ONZ·TTCA·MeOH, C 7 H 10 ClN 3 O 3 ·C 3 H 3 N 3 S 3 ·CH 3 OH, and ONZ·TTCA·H 2 O, C 7 H 10 ClN 3 O 3 ·C 3 H 3 N 3 S 3 ·H 2 O) and ronidazole (RNZ·TTCA and 2RNZ·2TTCA, both C 6 H 8 N 4 O 4 ·C 3 H 3 N 3 S 3 ) were investigated to identify recurring drug–coformer aggregation patterns and factors determining supramolecular architecture. Structural analysis showed that TTCA adopts two principal supramolecular motifs: the hydrogen-bonded R 2 2 (8) dimer and linear chain assemblies. Two dominant drug–coformer binding schemes were identified. The first involves N—H...N hydrogen bonding in the para position relative to the TTCA dimer, leading to four-molecule assemblies, which are accompanied by heteronuclear hydrogen bonding in the ortho position. The second motif is associated with TTCA linear chains, where drug molecules are linked through N—H...N interactions and further stabilized by direct intermolecular or solvent-mediated hydrogen bonding. The polymorphic structure 2RNZ·2TTCA combines both supramolecular strategies within a single-crystal architecture. Hirshfeld surface analysis and intermolecular energy calculations confirmed the importance of hydrogen-bond competition in determining the crystal packing and supramolecular organization in TTCA-based cocrystals.
- 19 February 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (11) , 2254-2260
Regio- and stereoselective ring-opening of aziridines: a click chemistry approach to chiral amino alcohols and triazole-modified compounds
The presented paper describes a regio- and stereoselective method for synthesizing of chiral amino alcohol derivatives from simple, readily available substrates such as chiral epoxides and chiral aziridines.
- 19 February 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (11) , 2254-2260
Regio- and stereoselective ring-opening of aziridines: a click chemistry approach to chiral amino alcohols and triazole-modified compounds
The presented paper describes a regio- and stereoselective method for synthesizing of chiral amino alcohol derivatives from simple, readily available substrates such as chiral epoxides and chiral aziridines.
- 15 January 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (6) , 784-794
The N–H⋯S hydrogen bonding pattern in trithiocyanuric acid in crystalline state: geometric, topological, and energetic analysis of trithiocyanuric acid cocrystals
Four new crystal structures of trithiocyanuric acid (TTCA) with diazine derivatives have been determined, revealing key N–H⋯S interactions that stabilize molecular aggregates. TTCA forms two types of chains—linear and zigzag—each with distinct structural characteristics. Geometry and Hirshfeld surface analyses, supported by quantum-theoretical calculations, demonstrate that both chain arrangements are equally feasible, arising from inherent preferences in the crystal's structural organization. The critical role of intermolecular hydrogen bonds, particularly those involving amine groups as proton donors, in stabilizing these cocrystals is highlighted. To analyze the energy parameters, we applied the many-body extension of the supramolecular interaction energy approach for chain complexes in their crystal-state geometry, allowing decomposition of the interaction energy into two- and many-body contributions. The prevalent hydrogen bonding synthon, R2 2(8), which forms both linear and zigzag chain structures, was found to be crucial in stabilizing the TTCA aggregates.
- 15 January 2025
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 27 (6) , 784-794
The N–H⋯S hydrogen bonding pattern in trithiocyanuric acid in crystalline state: geometric, topological, and energetic analysis of trithiocyanuric acid cocrystals
Four new crystal structures of trithiocyanuric acid (TTCA) with diazine derivatives have been determined, revealing key N–H⋯S interactions that stabilize molecular aggregates. TTCA forms two types of chains—linear and zigzag—each with distinct structural characteristics. Geometry and Hirshfeld surface analyses, supported by quantum-theoretical calculations, demonstrate that both chain arrangements are equally feasible, arising from inherent preferences in the crystal's structural organization. The critical role of intermolecular hydrogen bonds, particularly those involving amine groups as proton donors, in stabilizing these cocrystals is highlighted. To analyze the energy parameters, we applied the many-body extension of the supramolecular interaction energy approach for chain complexes in their crystal-state geometry, allowing decomposition of the interaction energy into two- and many-body contributions. The prevalent hydrogen bonding synthon, R2 2(8), which forms both linear and zigzag chain structures, was found to be crucial in stabilizing the TTCA aggregates.
- 22 May 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (23) , 9732-9740
Amine-catalyzed substitution in CpFe(CO)2I by phosphine and bisphosphine ligands
Amines significantly accelerate iodide substitution in CpFe(CO)2I with phosphines.
- 22 May 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (23) , 9732-9740
Amine-catalyzed substitution in CpFe(CO)2I by phosphine and bisphosphine ligands
Amines significantly accelerate iodide substitution in CpFe(CO)2I with phosphines.
- Open Access
- 7 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5081
Silver Complexes of Miconazole and Metronidazole: Potential Candidates for Melanoma Treatment
Melanoma, arguably the deadliest form of skin cancer, is responsible for the majority of skin-cancer-related fatalities. Innovative strategies concentrate on new therapies that avoid the undesirable effects of pharmacological or medical treatment. This article discusses the chemical structures of [(MTZ)2AgNO3], [(MTZ)2Ag]2SO4, [Ag(MCZ)2NO3], [Ag(MCZ)2BF4], [Ag(MCZ)2SbF6] and [Ag(MCZ)2ClO4] (MTZ—metronidazole; MCZ—miconazole) silver(I) compounds and the possible relationship between the molecules and their cytostatic activity against melanoma cells. Molecular Hirshfeld surface analysis and computational methods were used to examine the possible association between the structure and anticancer activity of the silver(I) complexes and compare the cytotoxicity of the silver(I) complexes of metronidazole and miconazole with that of silver(I) nitrate, cisplatin, metronidazole and miconazole complexes against A375 and BJ cells. Additionally, these preliminary biological studies found the greatest IC50 values against the A375 line were demonstrated by [Ag(MCZ)2NO3] and [(MTZ)2AgNO3]. The compound [(MTZ)2AgNO3] was three-fold more toxic to the A375 cells than the reference (cisplatin) and 15 times more cytotoxic against the A375 cells than the normal BJ cells. Complexes of metronidazole with Ag(I) are considered biocompatible at a concentration below 50 µmol/L.
- 7 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5081
Open AccessSilver Complexes of Miconazole and Metronidazole: Potential Candidates for Melanoma Treatment
Melanoma, arguably the deadliest form of skin cancer, is responsible for the majority of skin-cancer-related fatalities. Innovative strategies concentrate on new therapies that avoid the undesirable effects of pharmacological or medical treatment. This article discusses the chemical structures of [(MTZ)2AgNO3], [(MTZ)2Ag]2SO4, [Ag(MCZ)2NO3], [Ag(MCZ)2BF4], [Ag(MCZ)2SbF6] and [Ag(MCZ)2ClO4] (MTZ—metronidazole; MCZ—miconazole) silver(I) compounds and the possible relationship between the molecules and their cytostatic activity against melanoma cells. Molecular Hirshfeld surface analysis and computational methods were used to examine the possible association between the structure and anticancer activity of the silver(I) complexes and compare the cytotoxicity of the silver(I) complexes of metronidazole and miconazole with that of silver(I) nitrate, cisplatin, metronidazole and miconazole complexes against A375 and BJ cells. Additionally, these preliminary biological studies found the greatest IC50 values against the A375 line were demonstrated by [Ag(MCZ)2NO3] and [(MTZ)2AgNO3]. The compound [(MTZ)2AgNO3] was three-fold more toxic to the A375 cells than the reference (cisplatin) and 15 times more cytotoxic against the A375 cells than the normal BJ cells. Complexes of metronidazole with Ag(I) are considered biocompatible at a concentration below 50 µmol/L.
- 29 August 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 79 (9) , 374-380
2,2′-Dithiobispyrazine: about the disulfide bond
X-ray diffraction studies reveal that pyrazine-2-thiol undergoes condensation to 2,2′-dithiobispyrazine [systematic name: 2-(pyrazin-2-yldisulfanyl)pyrazine], C8H6N4S2 (I), under aerial conditions. In the molecule of I, the pyrazine rings are arranged in an almost perpendicular manner, with an absolute value of the C—S—S—C torsion angle of −91.45 (6)°. A search in the Cambridge Structural Database confirmed that such a conformation is typical for disulfide compounds. Three different rotamers of disulfide I were studied using quantum theoretical studies. The rotamer of lowest energy was observed in the crystalline state in the structure stabilized by hydrogen-bond, chalcogen-bond and stacking interactions. Further quantum chemical computations confirm that 2,2′-dithiobispyrazine can react according to the SN2 mechanism.
- 29 August 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 79 (9) , 374-380
2,2′-Dithiobispyrazine: about the disulfide bond
X-ray diffraction studies reveal that pyrazine-2-thiol undergoes condensation to 2,2′-dithiobispyrazine [systematic name: 2-(pyrazin-2-yldisulfanyl)pyrazine], C8H6N4S2 (I), under aerial conditions. In the molecule of I, the pyrazine rings are arranged in an almost perpendicular manner, with an absolute value of the C—S—S—C torsion angle of −91.45 (6)°. A search in the Cambridge Structural Database confirmed that such a conformation is typical for disulfide compounds. Three different rotamers of disulfide I were studied using quantum theoretical studies. The rotamer of lowest energy was observed in the crystalline state in the structure stabilized by hydrogen-bond, chalcogen-bond and stacking interactions. Further quantum chemical computations confirm that 2,2′-dithiobispyrazine can react according to the SN2 mechanism.
- Open Access
- 10 March 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (13) , 4237-4250
Piano-stool ruthenium(ii) complexes with maleimide and phosphine or phosphite ligands: synthesis and activity against normal and cancer cells
In these studies, we designed and investigated cyto- and genotoxic potential of five ruthenium cyclopentadienyl complexes bearing different phosphine and phosphite ligands. All of the complexes were characterized with spectroscopic analysis (NMR, FT-IR, ESI-MS, UV-vis, fluorescence and XRD (for two compounds)). For biological studies, we used three types of cells – normal peripheral blood mononuclear (PBM) cells, leukemic HL-60 cells and doxorubicin-resistance HL-60 cells (HL-60/DR). We compared the results obtained with those obtained for the complex with maleimide ligand CpRu(CO)2(η1-N-maleimidato) 1, which we had previously reported. We observed that the complexes CpRu(CO)(PPh3)(η1-N-maleimidato) 2a and CpRu(CO)(P(OEt)3)(η1-N-maleimidato) 3a were the most cytotoxic for HL-60 cells and non-cytotoxic for normal PBM cells. However, complex 1 was more cytotoxic for HL-60 cells than complexes 2a and 3a (IC50 = 6.39 μM vs. IC50 = 21.48 μM and IC50 = 12.25 μM, respectively). The complex CpRu(CO)(P(OPh)3)(η1-N-maleimidato) 3b is the most cytotoxic for HL-60/DR cells (IC50 = 104.35 μM). We found the genotoxic potential of complexes 2a and 3a only in HL-60 cells. These complexes also induced apoptosis in HL-60 cells. Docking studies showed that complexes 2a and CpRu(CO)(P(Fu)3)(η1-N-maleimidato) 2b have a small ability to degrade DNA, but they may cause a defect in DNA damage repair mechanisms leading to cell death. This hypothesis is corroborated with the results obtained in the plasmid relaxation assay in which ruthenium complexes bearing phosphine and phosphite ligands induce DNA breaks.
- 10 March 2023
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 52 (13) , 4237-4250
Open AccessPiano-stool ruthenium(ii) complexes with maleimide and phosphine or phosphite ligands: synthesis and activity against normal and cancer cells
In these studies, we designed and investigated cyto- and genotoxic potential of five ruthenium cyclopentadienyl complexes bearing different phosphine and phosphite ligands. All of the complexes were characterized with spectroscopic analysis (NMR, FT-IR, ESI-MS, UV-vis, fluorescence and XRD (for two compounds)). For biological studies, we used three types of cells – normal peripheral blood mononuclear (PBM) cells, leukemic HL-60 cells and doxorubicin-resistance HL-60 cells (HL-60/DR). We compared the results obtained with those obtained for the complex with maleimide ligand CpRu(CO)2(η1-N-maleimidato) 1, which we had previously reported. We observed that the complexes CpRu(CO)(PPh3)(η1-N-maleimidato) 2a and CpRu(CO)(P(OEt)3)(η1-N-maleimidato) 3a were the most cytotoxic for HL-60 cells and non-cytotoxic for normal PBM cells. However, complex 1 was more cytotoxic for HL-60 cells than complexes 2a and 3a (IC50 = 6.39 μM vs. IC50 = 21.48 μM and IC50 = 12.25 μM, respectively). The complex CpRu(CO)(P(OPh)3)(η1-N-maleimidato) 3b is the most cytotoxic for HL-60/DR cells (IC50 = 104.35 μM). We found the genotoxic potential of complexes 2a and 3a only in HL-60 cells. These complexes also induced apoptosis in HL-60 cells. Docking studies showed that complexes 2a and CpRu(CO)(P(Fu)3)(η1-N-maleimidato) 2b have a small ability to degrade DNA, but they may cause a defect in DNA damage repair mechanisms leading to cell death. This hypothesis is corroborated with the results obtained in the plasmid relaxation assay in which ruthenium complexes bearing phosphine and phosphite ligands induce DNA breaks.
- 1 February 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 79 (2) , 52-60
X-ray studies of three 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine cocrystals: an unexpected molecular conformation stabilized by hydrogen bonds
The results of the X-ray structure analysis of three novel 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine cocrystals are presented. These are 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–2,4,6-tribromophenol (1/2), C12H8N6·2C6H3Br3O, 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–isonicotinic acid N-oxide (1/2), C12H8N6·2C6H5NO3, and 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–4-nitrobenzenesulfonamide (1/1), C12H8N6·C6H6N2O4S. Special attention is paid to a conformational analysis of the title tetrazine molecule in known crystal structures. Quantum chemistry methods are used to compare the energetic parameters of the investigated conformations. A structural analysis of the hydrogen and halogen bonds with acceptor aromatic tetrazine and pyrazine rings is conducted in order to elucidate factors responsible for conformational stability.
- 1 February 2023
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section C Structural Chemistry
- Vol. 79 (2) , 52-60
X-ray studies of three 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine cocrystals: an unexpected molecular conformation stabilized by hydrogen bonds
The results of the X-ray structure analysis of three novel 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine cocrystals are presented. These are 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–2,4,6-tribromophenol (1/2), C12H8N6·2C6H3Br3O, 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–isonicotinic acid N-oxide (1/2), C12H8N6·2C6H5NO3, and 3,6-bis(pyridin-2-yl)-1,2,4,5-tetrazine–4-nitrobenzenesulfonamide (1/1), C12H8N6·C6H6N2O4S. Special attention is paid to a conformational analysis of the title tetrazine molecule in known crystal structures. Quantum chemistry methods are used to compare the energetic parameters of the investigated conformations. A structural analysis of the hydrogen and halogen bonds with acceptor aromatic tetrazine and pyrazine rings is conducted in order to elucidate factors responsible for conformational stability.
- Open Access
- 27 June 2022
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (32) , 5688-5696
Novel melamine – salicylic salt solvates and co-crystals; an analysis of the energetic parameters of the intermolecular hydrogen bonds stabilizing the crystal structure
Two novel crystal structures based on melamine and salicylic acid, with either water (I) (4:3:8 molecular ratio) or ethanol (II) (2:2:1 molecular ratio), can be treated as salt solvates. In these structures, all molecular components are bound by expanded hydrogen bonding networks consisting of N-H...N, N-H...O, O-H...O, O-H…N interactions among the solvent molecules and acid-base complexes; these stabilize the crystal architecture. Special attention is paid to the N+-H….O- hydrogen bonds formed between cationic melamine molecules and the ionized carboxyl group (COO-) of anions of salicylic acid. These salt bridges exist as single contact or bifurcated double donor/acceptor hydrogen bonds which are additionally accompanied by N-H…O interactions. This present study uses quantum chemistry methods (DFT, QTAIM) to understand their nature and their energetic parameters.
- 27 June 2022
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 24 (32) , 5688-5696
Open AccessNovel melamine – salicylic salt solvates and co-crystals; an analysis of the energetic parameters of the intermolecular hydrogen bonds stabilizing the crystal structure
Two novel crystal structures based on melamine and salicylic acid, with either water (I) (4:3:8 molecular ratio) or ethanol (II) (2:2:1 molecular ratio), can be treated as salt solvates. In these structures, all molecular components are bound by expanded hydrogen bonding networks consisting of N-H...N, N-H...O, O-H...O, O-H…N interactions among the solvent molecules and acid-base complexes; these stabilize the crystal architecture. Special attention is paid to the N+-H….O- hydrogen bonds formed between cationic melamine molecules and the ionized carboxyl group (COO-) of anions of salicylic acid. These salt bridges exist as single contact or bifurcated double donor/acceptor hydrogen bonds which are additionally accompanied by N-H…O interactions. This present study uses quantum chemistry methods (DFT, QTAIM) to understand their nature and their energetic parameters.
- 7 February 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (4) , e6595
Cytotoxicity of piano‐stool ruthenium cyclopentadienyl complexes bearing different imidato ligands
In these studies, we investigated a cytotoxic and genotoxic potential of four ruthenium cyclopentadienyl complexes bearing different imidato ligands: (η5‐cyclopentadienyl)Ru (CO)2(η1‐N‐maleimidato) (1), (η5‐cyclopentadienyl)Ru (CO)2‐N‐methoxysuccinimidato (2), (η5‐cyclopentadienyl)Ru (CO)2‐N‐ethoxysuccinimidato (3), and (η5‐cyclopentadienyl)Ru (CO)2‐N‐phthalimidato (4). We used two types of cells—normal peripheral blood mononuclear cells (PBMCs) and leukemic HL‐60 cells. We observed that complex 1 was highly cytotoxic and genotoxic, both for normal and cancer cells at concentrations from 0.5 to 250 μM. Interestingly, complex 1 was 10 times more cytotoxic to HL‐60 cells compared with PBMCs. Complexes 2–4 were cytotoxic only for HL‐60 cells at the highest used concentrations. Furthermore, we observed an increase in the viability of PBMCs after incubation with succinimide complexes 2 and 3. We also showed that complex 1 arrested cell cycle in the sub‐G1 phase and induced apoptosis. We found that different properties of studied ruthenium complexes depend significantly on the type of imide ligand bind to the ruthenium atom. The density functional theory (DFT) calculation of maleimide and succinimide revealed some significant differences of these compounds that would be related to biological activity. Our results indicate that ruthenium complex 1 should be further investigated in detail for its anticancer properties.
- 7 February 2022
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (4) , e6595
Cytotoxicity of piano‐stool ruthenium cyclopentadienyl complexes bearing different imidato ligands
In these studies, we investigated a cytotoxic and genotoxic potential of four ruthenium cyclopentadienyl complexes bearing different imidato ligands: (η5‐cyclopentadienyl)Ru (CO)2(η1‐N‐maleimidato) (1), (η5‐cyclopentadienyl)Ru (CO)2‐N‐methoxysuccinimidato (2), (η5‐cyclopentadienyl)Ru (CO)2‐N‐ethoxysuccinimidato (3), and (η5‐cyclopentadienyl)Ru (CO)2‐N‐phthalimidato (4). We used two types of cells—normal peripheral blood mononuclear cells (PBMCs) and leukemic HL‐60 cells. We observed that complex 1 was highly cytotoxic and genotoxic, both for normal and cancer cells at concentrations from 0.5 to 250 μM. Interestingly, complex 1 was 10 times more cytotoxic to HL‐60 cells compared with PBMCs. Complexes 2–4 were cytotoxic only for HL‐60 cells at the highest used concentrations. Furthermore, we observed an increase in the viability of PBMCs after incubation with succinimide complexes 2 and 3. We also showed that complex 1 arrested cell cycle in the sub‐G1 phase and induced apoptosis. We found that different properties of studied ruthenium complexes depend significantly on the type of imide ligand bind to the ruthenium atom. The density functional theory (DFT) calculation of maleimide and succinimide revealed some significant differences of these compounds that would be related to biological activity. Our results indicate that ruthenium complex 1 should be further investigated in detail for its anticancer properties.